Genetics can predict and help improve outcomes after bariatric surgery
Clinicians treating severe obesity have a new genetic tool for predicting and ultimately improving bariatric surgery outcomes, according...
top of page
Browse by category
Search
NICE draft guidance approves of ESG as an option to treat obesity
The UK’s National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that endoscopic sleeve gastroplasty...
European Medicines Agency to discuss anaesthesia risk for weight-loss drugs
The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
Soleno reveals positive results from DCCR for Prader-Willi Syndrome
Soleno Therapeutics has announced positive top-line results from the randomised withdrawal period of Study C602, a long-term treatment...
Women with obesity have worse menopause symptoms and get less relief from hormone therapy
Obesity may worsen a woman’s menopause symptoms and limit the amount of relief she gets from hormone therapy (HT), according to the...
Tirzepatide more effective in blood sugar control and body weight loss than semaglutide
A new meta-analysis combining 22 studies shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms...
Browse by tag
bottom of page